Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule

Guidelines for preclinical animal research in ALS/MND: A consensus meeting

(2010) Albert C. Ludolph et al.   Amyotrophic Lateral Sclerosis

IGF-1:Tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice

(2009) Ru-Ju Chian et al.   BRAIN RESEARCH

Gab1 transduces PI3K-mediated erythropoietin signals to the Erk pathway and regulates erythropoietin-dependent proliferation and survival of erythroid cells

(2009) Tetsuya Fukumoto et al.   CELLULAR SIGNALLING

Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis

(2009) Lana Kupershmidt et al.   FASEB JOURNAL

Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy

(2009) María Moreno-Igoa et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Cytoskeletal and Activity-Related Changes in Spinal Motoneurons after Root Avulsion

(2009) Clara Penas et al.   JOURNAL OF NEUROTRAUMA

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS

(2008) B TURNER et al.   PROGRESS IN NEUROBIOLOGY